144 related articles for article (PubMed ID: 24325382)
1. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response.
Thackaberry EA; Farman C; Zhong F; Lorget F; Staflin K; Cercillieux A; Miller PE; Schuetz C; Chang D; Famili A; Daugherty AL; Rajagopal K; Bantseev V
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4274-4285. PubMed ID: 28850638
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
[TBL] [Abstract][Full Text] [Related]
4. Etoposide-Loaded Poly(Lactic-co-Glycolic Acid) Intravitreal Implants: In Vitro and In Vivo Evaluation.
Solano AGR; de Fátima Pereira A; de Faria LGA; Fialho SL; de Oliveira Patricio PS; da Silva-Cunha A; Fulgêncio GO; da Silva GR; Pianetti GA
AAPS PharmSciTech; 2018 May; 19(4):1652-1661. PubMed ID: 29516291
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
6. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
[TBL] [Abstract][Full Text] [Related]
7. Development of a method to quantify clindamycin in vitreous humor of rabbits' eyes by UPLC-MS/MS: application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation.
Fernandes-Cunha GM; Gouvea DR; Fulgêncio Gde O; Rezende CM; da Silva GR; Bretas JM; Fialho SL; Lopes NP; Silva-Cunha A
J Pharm Biomed Anal; 2015 Jan; 102():346-52. PubMed ID: 25459934
[TBL] [Abstract][Full Text] [Related]
8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
[TBL] [Abstract][Full Text] [Related]
10. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
11. In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.
de Almeida FP; Saliba JB; Ribeiro JA; Siqueira RC; Fialho SL; Silva-Cunha A; Jorge R; Messias A
Doc Ophthalmol; 2015 Dec; 131(3):207-14. PubMed ID: 26576763
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis.
Ishikawa T; Hokama H; Katagiri Y; Goto H; Usui M
Curr Eye Res; 2005 Feb; 30(2):93-101. PubMed ID: 15814467
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
Manna S; Caixeta Faraj RQ; Riemann B; Rao MB; Nair V; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
Exp Eye Res; 2021 Apr; 205():108505. PubMed ID: 33617850
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant.
Mai S; Lin L; Yang W; Deng X; Xie Z; Zong Y; Li Y; Gao Q
J Ocul Pharmacol Ther; 2014 Oct; 30(8):670-80. PubMed ID: 24933028
[TBL] [Abstract][Full Text] [Related]
16. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
[TBL] [Abstract][Full Text] [Related]
18. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
Rodríguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-Loaded Intravitreal Implant for Effective Treatment of Experimental Uveitis.
Paiva MRB; Vasconcelos-Santos DV; Vieira LC; Fialho SL; Silva-Cunha A
AAPS PharmSciTech; 2021 Jan; 22(1):35. PubMed ID: 33404988
[TBL] [Abstract][Full Text] [Related]
20. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
